Neurocrine Biosciences
NBIX
#1241
Rank
HK$111.51 B
Marketcap
HK$1,101
Share price
1.38%
Change (1 day)
6.20%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

EPS for Neurocrine Biosciences (NBIX)

EPS in 2023 (TTM): HK$15.33

According to Neurocrine Biosciences 's latest financial reports the company's current EPS (TTM) is HK$15.26. In 2022 the company made an earnings per share (EPS) of HK$12.54 an increase over its 2021 EPS that were of HK$7.40.

EPS history for Neurocrine Biosciences from 1997 to 2023

Annual EPS

Year EPS Change
2023 (TTM)HK$15.3322.24%
2022HK$12.5469.47%
2021HK$7.40-78.21%
2020HK$33.95990%
2019HK$3.1181.82%
2018HK$1.71-113.5%
2017-HK$12.690.62%
2016-HK$12.6257.28%
2015-HK$8.0225.61%
2014-HK$6.3918.84%
2013-HK$5.37-1085.71%
2012HK$0.55-89.71%
2011HK$5.30-500%
2010-HK$1.32-86.92%
2009-HK$10.12-43.48%
2008-HK$17.91-57.8%
2007-HK$42.4492.58%
2006-HK$22.04371.67%
2005-HK$4.67-52.76%
2004-HK$9.8936.56%
2003-HK$7.24-70%
2002-HK$24.14118.31%
2001-HK$11.068.4%
2000-HK$10.2048.86%
1999-HK$6.85-20%
1998-HK$8.57-479.31%
1997HK$2.26

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
HK$16.28 6.63%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$4.28-71.94%๐Ÿ‡ฌ๐Ÿ‡ง UK
-HK$23.05-251.02%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$42.28 177.00%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$28.66 87.79%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$14.48-5.10%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$3.66-123.98%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$23.60-254.59%๐Ÿ‡บ๐Ÿ‡ธ USA